Its action mimics the natural GLP-1 and GIP hormones, helping to regulate the bodys energy balance and glucose control more effectively
Its best to weigh yourself at the same time every day, ideally in the morning before eating, for consistent results
Sources MHRA Drug Safety Update Semaglutide (Wegovy, Ozempic and Rybelsus): risk of Non-arteritic Anterior Ischemic Optic Neuropathy (NAION), 5 February 2026 BMJ Semaglutide and NAION, February 2026 Community Pharmacy England MHRA Drug Safety Update: Semaglutide and NAION, 5 February 2026 NowPatient has taken all reasonable steps to ensure that all material is factually accurate, complete, and current
the IP is fully owned by Novo Nordisk, who markets both compounds for the treatment for obesity and/or diabetes
Both Eli Lilly and Novo Nordisk have made billions charging as much for these drugs as the market will allow